Nanos Market Share Analysis for May 2026

north american neuro-ophthalmology society is a professional organization with more than 800 members who are fully trained neurologists

Health > Medicine

Domainnanosweb.org

Year Founded--

Employees501 - 1000

Annual Revenue--

Nanos

Nanos (including company regionals)

nanosweb.org

See more website traffic and engagement information

Total visits to Nanos's top domains

Understand Nanos market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

nanosweb.org47.4K

See more with Sales Intelligence

Avg. visit duration in Nanos's top domains

Analyze Nanos engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

nanosweb.org00:00:53

See more with Sales Intelligence

Avg. pageviews on Nanos's top domains

See how Nanos keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

nanosweb.org1.53

See more with Sales Intelligence

Nanos top competitors by domain

Top similar sites in May 2026, ranked by their affinity

spine.orgCompany NameNorth American Spine SocietyEmployees51 - 200HQUnited States, Louisiana, Baton RougeAnnual revenue$5M - $10MTotal visits44.8KHealth > Medicine

Top technologies used by Nanos

These are the website technologies, by industry, used by Nanos top domains

Audio Video Media (5)

YouTube

Mobile (3)

Meta Viewport

Social (3)

Instagram

Widget (3)

reCAPTCHA

More Technologies

9

See all

News & Signals from Nanos

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNanosweb attended event 52nd Annual Meeting on Mar 16th '26.ZUG, Switzerland, March 16, 2026 (GLOBE NEWSWIRE) - Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (Oculis), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in ophthalmology and neuro-ophthalmology, today announced the presentation of the ACUITY Phase 2 data with Privosegtor at the North American Neuro-Ophthalmology Society (NANOS) 52nd Annual Meeting.